LALPATHLAB Stock Performance

<div class='circular--portrait' style='background:#FF6600;color: #FFFAFA;font-size:4em;padding-top: 25px;;'>DL</div>
LALPATHLAB -- India Stock  

INR 1,782  39.75  2.18%

On a scale of 0 to 100, DR LAL holds a performance score of 10. The firm owns a Beta (Systematic Risk) of -0.1853, which means not very significant fluctuations relative to the market. Let's try to break down what LALPATHLAB's beta means in this case. As returns on the market increase, returns on owning DR LAL are expected to decrease at a much lower rate. During the bear market, DR LAL is likely to outperform the market. Although it is vital to follow DR LAL PATHLABS existing price patterns, it is good to be conservative about what you can do with the information regarding equity price patterns. The way in which we are predicting future performance of any stock is to evaluate the business as a whole together with its past performance, including all available fundamental and technical indicators. By examining DR LAL PATHLABS technical indicators, you can at this moment evaluate if the expected return of 0.33% will be sustainable into the future. Please utilizes DR LAL PATHLABS downside deviation, treynor ratio, expected short fall, as well as the relationship between the variance and potential upside to make a quick decision on whether DR LAL PATHLABS current price history will revert.

Search Stock Performance

 
Refresh
1010

DR LAL Risk-Adjusted Performance

Compared to the overall equity markets, risk-adjusted returns on investments in DR LAL PATHLABS are ranked lower than 10 (%) of all global equities and portfolios over the last 30 days. Despite nearly weak basic indicators, DR LAL layed out solid returns over the last few months and may actually be approaching a breakup point.
Quick Ratio3.60
Fifty Two Week Low1,031.45
Target High Price1,320.00
Fifty Two Week High1,846.00
Payout Ratio32.58%
Trailing Annual Dividend Yield0.77%
Target Low Price720.00

DR LAL Relative Risk vs. Return Landscape

If you would invest  149,640  in DR LAL PATHLABS on June 14, 2020 and sell it today you would earn a total of  28,585  from holding DR LAL PATHLABS or generate 19.1% return on investment over 30 days. DR LAL PATHLABS is generating 0.3345% of daily returns and assumes 2.1242% volatility on return distribution over the 30 days horizon. Simply put, 18% of equities are less volatile than DR LAL and 94% of equity instruments are likely to generate higher returns than the company over the next 30 trading days.
 Daily Expected Return (%) 
      Risk (%) 
Assuming the 30-days trading horizon, DR LAL is expected to generate 1.18 times more return on investment than the market. However, the company is 1.18 times more volatile than its market benchmark. It trades about 0.16 of its potential returns per unit of risk. The DOW is currently generating roughly 0.1 per unit of risk.

DR LAL Market Risk Analysis

Sharpe Ratio = 0.1575
Best
Portfolio
Best
Equity
Good Returns
Average Returns
Small ReturnsLALPATHLAB
CashSmall
Risk
Average
Risk
High
Risk
Huge
Risk
Negative Returns

DR LAL Stock Performance Indicators

Estimated Market Risk
 2.12
  actual daily
 
 18 %
of total potential
 
1818
Expected Return
 0.33
  actual daily
 
 6 %
of total potential
 
66
Risk-Adjusted Return
 0.16
  actual daily
 
 10 %
of total potential
 
1010
Based on monthly moving average DR LAL is performing at about 10% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of DR LAL by adding it to a well-diversified portfolio.

About DR LAL Performance

To evaluate DR LAL PATHLABS Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when DR LAL generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare LALPATHLAB's stock performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand DR LAL PATHLABS stock market performance in a much more refined way. At Macroaxis, we take it even further. The Macroaxis performance score is an integer between 0 and 100 that represents LALPATHLAB's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section. Please also refer to our technical analysis and fundamental analysis pages.
Lal PathLabs Limited provides diagnostic and related healthcare tests and services in India and internationally. Lal PathLabs Limited was founded in 1949 and is based in Gurugram, India. DR LAL operates under Diagnostics Research classification in India and is traded on National Stock Exchange of India.

DR LAL Alerts

Equity Alerts and Improvement Suggestions

About 60.0% of the company outstanding shares are owned by corporate insiders

DR LAL Dividends

DR LAL PATHLABS Dividends Analysis

Check DR LAL PATHLABS dividend payout schedule and payment analysis over time. Analyze past dividends calendar and estimate annual dividend income
Check Dividends  
Additionally, see Stocks Correlation. Please also try Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page